The Laboratory of Molecular Hematology at UZ Brussel is organizing a postgraduate course on October 21, 2025, focused on minimal residual disease (MRD) in acute leukemia.
This full-day event will provide the latest insights into MRD detection and its impact on clinical decision-making. The morning sessions will cover topics related to acute lymphoblastic leukemia (ALL), while the afternoon will focus on MRD in acute myeloid leukemia (AML). Both molecular MRD (ASO qPCR, NGS-MRD, etc.) and Flow-MRD will be discussed in depth.
We are pleased to announce that Dew Doekharan (doekharan@bio-connectdiagnostics.nl) and Adam Verheyen (verheyen@bio-connect.nl) from Bio-Connect will be present at this event. They will be available to answer your questions and discuss the latest developments in MRD detection technologies.
For more information and registration, please visit the UZ Brussel event page.
We gladly support you by keeping you updated on our latest products and the developments around our services.
